Gracias Saldanha Founded Glenmark Pharmaceuticals with his pension fund in 1977 . By the time he died in 2012 , he had a fortune of $805 million and was the wealthiest Goan in the world. He hails from the Saligao village, out of which has come out many prominent Goans. He has two sons - Glenn Saldanha, CEO of Glenmark Pharmaceuticals.Mark Saldanha, Owner & CEO of Marksans Pharma.

HIS Contribution to Healthcare Landscape in India ;

He founded Glenmark Pharmaceuticals Limited - an Indian pharmaceutical company headquartered in Mumbai in 1977 as a generic drug and active pharmaceutical ingredient manufacturer. The generic products of this company have proven to be a boon for the Indian people in terms of affordability because of the reasonable prices. He has revolutionised the landscape of generic medicines in India.

Change-Making Positions Held ;

* He bet big on the discovery of new drugs, even while he continued to do business in generic drugs.
* New drug discovery is a risky and expensive business, but he dared to take the challenge.

Laurels Brought to Shree Gracias Saldanha ;

* "Glenmark has been built on the pillars of Integrity, Knowledge, Trust & Respect" under the leadership of Shree Gracias Saldanha.
* Glenmark received the Bombay Chamber of Commerce and Industry Civic Award 2014 - a prestigious recognition in the field of CSR.

Impact Brought in the Lives of Common Indians ;

Glenmark Pharmaceuticals brought inexpensive generic drugs to the easy reach of patients. In 2016 it had four such drugs in clinical trials. In June 2020, the company launched a potential COVID-19 drug Favipiravir under the brand name FabiFlu in India after studies found that there was some benefit of the drug in COVID-19 treatment. In August 2020, they also rolled out a higher strength version of FabiFlu.